Evidence map›Paper›PMID 33122310›Full record

ArticleBMJ open2020

Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO).

Svenja Specovius, Hanna G Zimmermann, Frederike Cosima Oertel, Claudia Chien, Charlotte Bereuter, Lawrence J Cook, Marco Aurélio Lana Peixoto, Mariana Andrade Fontenelle, Ho Jin Kim, Jae-Won Hyun and 49 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Clinical and neuroimaging findings in MOGAD-MRI and OCT.Clinical and experimental immunology · 2021
    Review
  13. Retinal Optical Coherence Tomography in Neuromyelitis Optica.Neurology(R) neuroimmunology & neuroinflammation · 2021
    Article
  14. Is serum angiotensin-converting enzyme a suitable biomarker for differentiating idiopathic and demyelinating optic neuritis?Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

59 authors at 20 institutions in 15 countries.

Svenja SpecoviusExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.ORCID 0000-0002-4572-4059
Hanna G ZimmermannExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Frederike Cosima OertelExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Claudia ChienExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Charlotte BereuterExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Lawrence J CookDepartment of Pediatrics, University of Utah, Salt Lake CIty, Utah, USA.
Marco Aurélio Lana PeixotoCIEM MS Research Center, University of Minas Gerais, Medical School, Belo Horizonte, Brazil.
Mariana Andrade FontenelleCIEM MS Research Center, University of Minas Gerais, Medical School, Belo Horizonte, Brazil.
Ho Jin KimDepartment of Neurology, National Cancer Center, Goyang, Republic of Korea.
Jae-Won HyunDepartment of Neurology, National Cancer Center, Goyang, Republic of Korea.
Su-Kyung JungDepartment of Ophthalmology, National Cancer Center, Goyang, Republic of Korea.
Jacqueline PalaceDepartment of Neurology, Oxford University Hospitals, National Health Service Trust, Oxford, UK.
Adriana Roca-FernandezNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Alejandro Rubio DiazDepartment of Neurology, Oxford University Hospitals, National Health Service Trust, Oxford, UK.
Maria Isabel LeiteDepartment of Neurology, Oxford University Hospitals, National Health Service Trust, Oxford, UK.
Srilakshmi M SharmaDepartment of Ophthalmology, Oxford University Hospitals, National Health Service Trust, Oxford, UK.
Fereshte AshtariKashani MS Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Rahele KafiehSchool of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Alireza DehghaniDepartment of Ophthalmology, Isfahan Eye Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohsen PouraziziDepartment of Ophthalmology, Isfahan Eye Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Lekha PanditDepartment of Neurology, KS Hegde Medical Academy, Nitte University, Mangalore, India.
Anitha DcunhaDepartment of Neurology, KS Hegde Medical Academy, Nitte University, Mangalore, India.
Orhan AktasDepartment of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Marius RingelsteinDepartment of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Philipp AlbrechtDepartment of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.ORCID 0000-0001-7987-658X
Eugene MaySwedish Neuroscience Institute Neuro-Ophthalmology, Seattle, Washington, USA.
Caryl TongcoSwedish Neuroscience Institute Neuro-Ophthalmology, Seattle, Washington, USA.
Letizia LeocaniNeurological Department and Institute of Experimental Neurology (INSPE) Scientific Institute, Hospital San Raffaele; and University Vita-Salute San Raffaele, Milan, Italy.
Marco PisaNeurological Department and Institute of Experimental Neurology (INSPE) Scientific Institute, Hospital San Raffaele; and University Vita-Salute San Raffaele, Milan, Italy.
Marta RadaelliNeurological Department and Institute of Experimental Neurology (INSPE) Scientific Institute, Hospital San Raffaele; and University Vita-Salute San Raffaele, Milan, Italy.
Elena H Martinez-LapiscinaHospital Clinic of Barcelona-Institut d'Investigacions, Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.
Hadas Stiebel-KalishSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Mark HellmannSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Itay LotanSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Sasitorn SirithoDivision of Neurology, Department of Medicine, Siriraj Hospital and Bumrungrad International Hospital, Bangkok, Thailand.
Jérôme de SezeNeurology Service, University Hospital of Strasbourg, Strasbourg, France.
Thomas SengerNeurology Service, University Hospital of Strasbourg, Strasbourg, France.
Joachim HavlaInstitute of Clinical Neuroimmunology, University Hospital, Ludwig Maximilians University, Munich, Germany.
Romain MarignierNeurology, Multiple Sclerosis, Myelin Disorders and Neuroinflammation, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Lyon, France.
Caroline TiliketeDepartment of Neuro-Ophthalmology, Hospices Civils de Lyon, Lyon, France.
Alvaro Cobo CalvoNeurology, Multiple Sclerosis, Myelin Disorders and Neuroinflammation, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Lyon, France.
Denis Bernardi BichuettiDepartamento de Neurologia e Neurocirurgia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Ivan Maynart TavaresDepartment of Ophthalmology and Visual Sciences, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.ORCID 0000-0003-2220-7603
Nasrin AsgariDepartments of Neurology, Slagelse Hospital, Slagelse, Denmark.
Kerstin SoelbergDepartments of Neurology, Slagelse Hospital, Slagelse, Denmark.
Ayse AltintasNeurology Department, School of Medicine, Koc University and Istanbul University - Cerrahpasa School of Medicine, Istanbul, Turkey.
Rengin YildirimDepartment of Ophthalmology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.
Uygur TanriverdiNeurology Department Istanbul, Istanbul University, Cerrahpasa School of Medicine, Istanbul, Turkey.
Anu JacobDepartment of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK.
Saif HudaDepartment of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK.
Zoe RimlerDepartment of Neurology, NYU Multiple Sclerosis Comprehensive Care Center, NYU School of Medicine, New York, New York, USA.
Allyson ReidDepartment of Neurology, NYU Multiple Sclerosis Comprehensive Care Center, NYU School of Medicine, New York, New York, USA.
Yang Mao-DraayerDepartment of Neurology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Ibis Soto de CastilloDepartment of Neurology, Hospital Clínico de Maracaibo, Maracaibo, Venezuela.
Michael R YeamanDepartment of Medicine, Los Angeles Biomedical Research Institute at Harbor-University of California at Los Angeles (UCLA) Medical Center, Torrance, California, USA.
Terry J SmithDepartments of Ophthalmology and Visual Sciences, Kellogg Eye Center, Ann Arbor, Michigan, USA.
Alexander U Brandt *Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Friedemann Paul *Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany friedemann.paul@charite.de.
GJCF International Clinical Consortium for NMOSD
Max Delbrück Center · DEIsfahan University of Medical Sciences · IRNational Health Service · GBHeinrich Heine University Düsseldorf · DEHospices Civils de Lyon · FRNational Cancer Center · KRTel Aviv University · ILVita-Salute San Raffaele University · ITMultiple Sclerosis Center Of Northeastern New York · USNitte University · INSwedish Medical Center · USUniversidade Federal de São Paulo · BRUniversité de Strasbourg · FRUniversity of Liverpool · GBUniversity of Michigan · USUniversity of Southern Denmark · DKConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHospital Universitario de Maracaibo · VEIstanbul University · TRIstanbul University-Cerrahpaşa · TR

Funding

Medical Research Council MR/T024682/1
6 · The paper itself

Abstract

purposeOptical coherence tomography (OCT) captures retinal damage in neuromyelitis optica spectrum disorders (NMOSD). Previous studies investigating OCT in NMOSD have been limited by the rareness and heterogeneity of the disease. The goal of this study was to establish an image repository platform, which will facilitate neuroimaging studies in NMOSD. Here we summarise the profile of the Collaborative OCT in NMOSD repository as the initial effort in establishing this platform. This repository should prove invaluable for studies using OCT to investigate NMOSD.

participantsThe current cohort includes data from 539 patients with NMOSD and 114 healthy controls. These were collected at 22 participating centres from North and South America, Asia and Europe. The dataset consists of demographic details, diagnosis, antibody status, clinical disability, visual function, history of optic neuritis and other NMOSD defining attacks, and OCT source data from three different OCT devices. FINDINGS TO DATE: The cohort informs similar demographic and clinical characteristics as those of previously published NMOSD cohorts. The image repository platform and centre network continue to be available for future prospective neuroimaging studies in NMOSD. For the conduct of the study, we have refined OCT image quality criteria and developed a cross-device intraretinal segmentation pipeline. FUTURE PLANS: We are pursuing several scientific projects based on the repository, such as analysing retinal layer thickness measurements, in this cohort in an attempt to identify differences between distinct disease phenotypes, demographics and ethnicities. The dataset will be available for further projects to interested, qualified parties, such as those using specialised image analysis or artificial intelligence applications.

Indexed as

Neuromyelitis OpticaArtificial IntelligenceAsiaEuropeHumansSouth AmericaTomography, Optical CoherenceVisual Acuitymedical retinaneurologyneuro-ophthalmologyradiology & imaging

Identifiers

PMID33122310
PMCPMC7597491
OpenAlexW3096450430

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.